Risk factors for clinician‐reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|6|848-854

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.6, 2014-03, pp. : 848-854

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Prognostic Factors for Patients with Recurrent Head and Neck Cancer: Implications for Randomized Trials

By  

Oncology, Vol. 61, Iss. 3, 2001-09 ,pp. : 197-204

Karger

Access to resources Recommend Favorite

Prevalence and risk factors of depressive disorder in caregivers of patients with head and neck cancer

By  

PSYCHO-ONCOLOGY (ELECTRONIC), Vol. 24, Iss. 2, 2015-02 ,pp. : 155-161

John Wiley & Sons Inc

Access to resources Recommend Favorite

Exploration of risk factors for weight loss in head and neck cancer patients

By  

Journal of Radiotherapy in Practice, Vol. 14, Iss. 4, 2015-07 ,pp. : 343-352

Cambridge University Press

Access to resources Recommend Favorite

Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first‐line treatment of patients with advanced breast cancer: Phase 3 randomized trial

By  

CANCER, Vol. 121, Iss. 19, 2015-10 ,pp. : 3412-3421

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical utility of the modified Glasgow prognostic score in patients with advanced head and neck cancer

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 12, 2015-12 ,pp. : 1745-1749

John Wiley & Sons Inc

Access to resources Recommend Favorite